Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)
Kazuya Okushin, Ryosuke Tateishi, Arata Takahashi, Koji Uchino, Ryo Nakagomi, T. Nakatsuka, Tatsuya Minami, Masaya Sato, Mitsuhiro Fujishiro, Kiyoshi Hasegawa, Yuichiro Eguchi, Tatsuya Kanto, Shoji Kubo, Hitoshi Yoshiji, Hiroaki Miyata, Namiki Izumi, Masatoshi Kudo, Kazuhiko Koike (2022). Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL). , 57(8), DOI: https://doi.org/10.1007/s00535-022-01893-5.
Article20 days agoResponse Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version)
Masatoshi Kudo, Masafumi Ikeda, Kazuomi Ueshima, Michiie Sakamoto, Shuichiro Shiina, Ryosuke Tateishi, Kazuhiro Nouso, Kiyoshi Hasegawa, Junji Furuse, Shiro Miyayama, Takamichi Murakami, Tatsuya Yamashita, Norihiro Kokudo (2022). Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version). , 52(4), DOI: https://doi.org/10.1111/hepr.13746.
Article20 days agoA multicenter, non-randomized, controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF-Cohort Trial): Analysis of overall survival.
Tatsuya Yamashita, Yoshikuni Kawaguchi, Shuichi Kaneko, Tadatoshi Takayama, Namiki Izumi, Naoki Yamanaka, Masatoshi Kudo, Mitsuo Shimada, Masafumi Inomata, Hideo Baba, Kazuhiko Koike, Masao Omata, Masatoshi Makuuchi, Yutaka Matsuyama, Norihiro Kokudo, Kiyoshi Hasegawa (2022). A multicenter, non-randomized, controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF-Cohort Trial): Analysis of overall survival.. , 40(16_suppl), DOI: https://doi.org/10.1200/jco.2022.40.16_suppl.4095.
Article20 days agoThe Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
Stephen L. Chan, Hui‐Chuan Sun, Yang Xu, Hongmei Zeng, Hashem B. El–Serag, Jeong Min Lee, Myron Schwartz, Richard S. Finn, Jinsil Seong, Xin Wei Wang, Tung‐Hung Su, Ghassan K. Abou‐Alfa, Lorenza Rimassa, Jia‐Horng Kao, Boheng Zhang, Josep M. Llovet, Jordi Bruix, Terry Cheuk-Fung Yip, Vincent Wai‐Sun Wong, Grace Lai-Hung Wong, Landon L. Chan, Manqi Liu, Qiang Gao, Feng Shen, Robin Kate Kelley, Ann‐Lii Cheng, Masayuki Kurosaki, Hidenori Toyoda, Weixia Chen, Takamichi Murakami, Ping Liang, Jessica Zucman‐Rossi, Yasunori Minami, Shiro Miyayama, Kui Wang, Kwan Man, Kiyoshi Hasegawa, Qiu Li, Kaoru Tsuchiya, Li Xu, Valerie Chew, Pierce K. H. Chow, Yoshihiko Hoshida, Amaia Lujambio, Irene Oi‐Lin Ng, Michiie Sakamoto, Young Nyun Park, Thomas Yau, Masatoshi Kudo, Jia Fan, Jian Zhou (2025). The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment. , 406(10504), DOI: https://doi.org/10.1016/s0140-6736(25)01042-6.
Article44 days agoA multicenter, non-randomized, controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF-Cohort Trial): Analysis of overall survival.
Tatsuya Yamashita, Yoshikuni Kawaguchi, Shuichi Kaneko, Tadatoshi Takayama, Namiki Izumi, Naoki Yamanaka, Masatoshi Kudo, Mitsuo Shimada, Masafumi Inomata, Hideo Baba, Kazuhiko Koike, Masao Omata, Masatoshi Makuuchi, Yutaka Matsuyama, Norihiro Kokudo, Kiyoshi Hasegawa, Masatoshi Kudo (2022). A multicenter, non-randomized, controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF-Cohort Trial): Analysis of overall survival.. , 40(16_suppl), DOI: https://doi.org/10.1200/jco.2022.40.16_suppl.4095.
Article20 days ago